Dataset Information


LRH-1-dependent programming of mitochondrial glutamine processing drives liver cancer.

ABSTRACT: Various tumors develop addiction to glutamine to support uncontrolled cell proliferation. Here we identify the nuclear receptor liver receptor homolog 1 (LRH-1) as a key regulator in the process of hepatic tumorigenesis through the coordination of a noncanonical glutamine pathway that is reliant on the mitochondrial and cytosolic transaminases glutamate pyruvate transaminase 2 (GPT2) and glutamate oxaloacetate transaminase 1 (GOT1), which fuel anabolic metabolism. In particular, we show that gain and loss of function of hepatic LRH-1 modulate the expression and activity of mitochondrial glutaminase 2 (GLS2), the first and rate-limiting step of this pathway. Acute and chronic deletion of hepatic LRH-1 blunts the deamination of glutamine and reduces glutamine-dependent anaplerosis. The robust reduction in glutaminolysis and the limiting availability of ?-ketoglutarate in turn inhibit mTORC1 signaling to eventually block cell growth and proliferation. Collectively, these studies highlight the importance of LRH-1 in coordinating glutamine-induced metabolism and signaling to promote hepatocellular carcinogenesis.


PROVIDER: S-EPMC4911925 | BioStudies | 2016-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4915131 | BioStudies
2017-01-01 | S-EPMC5566103 | BioStudies
2018-01-01 | S-EPMC5989844 | BioStudies
1000-01-01 | S-EPMC3408738 | BioStudies
2019-12-01 | E-MTAB-7541 | ArrayExpress
1000-01-01 | S-EPMC5922282 | BioStudies
2017-01-01 | S-EPMC5552314 | BioStudies
2016-01-01 | S-EPMC5108179 | BioStudies
1000-01-01 | S-EPMC4747359 | BioStudies
2016-01-01 | S-EPMC5035873 | BioStudies